Estate & Tax Planning

What happens on death: the process for families

The repayment window, the no-negative-equity guarantee, the option for beneficiaries to redeem, and what executors must do.

Illustrative photograph for the article: What happens on death: the process for families
Illustrative photography supplied by Equity Fountain. Images do not depict actual clients or cases and are used for presentation purposes only.

The plan ends on the death of the last borrower. Personal representatives notify the lender, interest continues to accrue at the contractual rate, and the lender allows a defined period — commonly twelve months — for the property to be sold and the loan repaid. Where the plan meets Equity Release Council standards, a no-negative-equity guarantee applies: the estate never owes more than the net sale proceeds, and beneficiaries cannot inherit the debt. Any surplus above the balance passes to the estate exactly as it would without the plan. Beneficiaries have a genuine choice. They may repay the loan from their own resources and retain the property, which is common where a family member wants to keep the home. Where the property is sold, most contracts permit repayment without an early repayment charge following the death of the last borrower. On the first death of a couple, nothing is triggered. The survivor continues on the same contract, at the same rate, with the same drawdown and repayment facilities. The practical adviser action is to leave the family a short written note — the lender, the plan reference, the contact number and the repayment window — with the client's will.

Client-friendly explanation

When the last borrower dies, the loan is repaid, usually from selling the home. Your family can never owe more than the property sells for, and they can choose to repay it and keep the house.

Last verified 2026-09-13 · Effective from 2026-09-13 · editorial

Information and software, not advice. Equity Fountain is not authorised or regulated by the Financial Conduct Authority and does not provide regulated financial, mortgage, equity-release, tax, legal or probate advice. It provides research tools, factual market information, modelling and educational resources for professional users. The subscribing adviser remains responsible for verification, suitability and client advice. Provider documentation takes precedence over anything shown here.

EFEquity Fountain

Equity Release Intelligence for the UK & Crown Dependencies

The fountain of knowledge for equity release professionals. Equity Fountain is an information and professional-resource platform for appropriately authorised financial services professionals. It does not provide personalised financial advice.

Source-referenced dataVerification dates shownEncrypted adviser data

Platform

Legal

Registered details

Equity FountainP O Box 8WilmslowCheshire SK9 5ESUnited KingdomCompany Registration No. 08753201VAT No. GB174 691576

Product availability, lending criteria, legal considerations and regulatory arrangements differ between England & Wales, Scotland, Jersey, Guernsey and the Isle of Man. Jurisdiction-specific requirements should be independently verified before reliance. Company registration in England and Wales does not mean Equity Fountain is regulated for services provided elsewhere.

Copyright © 2026 Maynard Procurement Solutions Ltd. All Rights Reserved. Equity Fountain is a trading name of Maynard Procurement Solutions Ltd, P O Box 8, Wilmslow, Cheshire SK9 5ES, United Kingdom. Company Registration No. 08753201. VAT No. GB174 691576.

Equity Fountain is registered in England and Wales under company number 08753201. Equity Fountain is not authorised or regulated by the Financial Conduct Authority and does not provide regulated financial advice. Information and tools provided through this website are for professional research, educational and informational purposes only. Product information, rates and criteria may change and should be independently verified before reliance.

Equity release will reduce the value of an estate and may affect entitlement to means-tested benefits. Product data shown is illustrative sample data pending a verified provider data load; provider documentation takes precedence where any discrepancy exists.